Tuesday, July 12, 2005

Healthcare: DNA and ABT

DNA and ABT may see some volume tomorrow. DNA reported yesterday with positive but expected news. ABT reports tomorrow morning at 10am EST i think. i really didnt think DNA's CC was that spectacular, but the call seems to have renewed a lot of interest in the company because of the many people who got rich a few months ago off DNA. jim cramer just recced DNA on maddmoney for 10 minutes. i dont really think his picks or opionions are very accurate, but a lot of retail buyers love cramer and they love DNA. in fact, i just watch maddmoney b/c its fun to watch cramer go crzy. i have no idea how it will go tomorrow, but if you see DNA trading up premarket, you may want to strategize accordingly (momentum/short/long). i'm bringing up ABT because i've heard a lot about it before in the past, and cramer just went out of his way to rec it during his lightning round. ABT has a very strong graph, imo. the stock has tested the $50 resistance 4 or 5 times during the last couple of months with sequentially rising supports. the chart is not showing any ambivalence going into the CC, and a good CC tomorrow w/ good Q2 financials could send the stock over the $50 resistance. i havent done my research on these companies so i'll be on the sidelines. its time for me to study for my midterm. good luck UPDATE: DNA is strong this morning while ABT isnt. looks like covered call writers win again.


Anonymous Anonymous said...

There's been talk about Avastin and its practicality. The issue is that it may not be that cost-efficient of a cancer drug considering its benefits. -F.

7/13/2005 12:51:00 AM  

Post a Comment

<< Home